HOME / SECTORS / DIGITAL & KNOWLEDGE / BIOTECHNOLOGY & PHARMA
Biotechnology & Pharma
Formulations, APIs, medical devices and clinical research across two dedicated parks.
BIOTECH PARKS
2
DISTRICTS
3
LAND AVAILABLE
160 acres
NODAL AGENCY
WBIDC
THE OPPORTUNITY
A clinical base most states cannot match
Bengal has one of India's largest concentrations of medical colleges and tertiary hospitals, which makes it unusually well placed for clinical research and trials — the constraint elsewhere is patient access, not capital. Alongside that, two biotech parks offer formulation, API and medical device manufacturing with effluent infrastructure already built.
INCENTIVES & POLICY
Capital investment subsidy
Up to 40% on eligible fixed capital investment, tiered by district category.
State GST reimbursement
Net State GST reimbursed for ten years from commercial production.
Biotech park incentive
Capital support for formulation, API and device manufacturing units.
Clinical research facilitation
Institutional linkage with state medical colleges and tertiary hospitals.
WHERE TO INVEST
BIOTECHNOLOGY & PHARMA — FILTERED SLICE OF THE BENGAL INVESTMENT GRID 2 · 3
YOUR NODAL OFFICER
Joint Director Biotechnology
Department of Biotechnology, Government of West Bengal. Replies within two working days.
UPCOMING FOR THIS SECTOR
IT/ITeS, AI, Deep Tech, Data Centres & Electronics Investor Meet
July 2027 · Kolkata
Register →